NCT02459899 - Dose-ranging Study in Patients With Type 1 Diabetes Mellitus | Biotech Hunter

Enrollment

141

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG

Placebo

Placebo, once daily, before the first meal of the day

DRUG

Sotagliflozin

Sotagliflozin,once daily, before the first meal of the day

Trial Locations (17)

20110

Lexicon Investigational Site, Manassas

20852

Lexicon Investigational Site, Rockville

23321

Lexicon Investigational Site, Chesapeake

27265

Lexicon Investigational Site, High Point

32225

Lexicon Investigational Site, Jacksonville

33175

Lexicon Investigational Site, Miami

43213

Lexicon Investigational Site, Columbus

59405

Lexicon Investigational Site, Great Falls

62711

Lexicon Investigational Site, Springfield

68114

Lexicon Investigational Site, Omaha

70006

Lexicon Investigational Site, Metairie

78229

Lexicon Investigational Site, San Antonio

80209

Lexicon Investigational Site, Denver

84107

Lexicon Investigational Site, Salt Lake City

93003

Lexicon Investigational Site, Ventura

94520

Lexicon Investigational Site, Concord

04210

Lexicon Investigational Site, Auburn